Inhibition of Phosphodiesterase 5 Promotes the Aromatase-Mediated Estrogen Biosynthesis in Osteoblastic Cells by Activation of cGMP/PKG/SHP2 Pathway.
Inhibition of Phosphodiesterase 5 Promotes the Aromatase-Mediated Estrogen Biosynthesis in Osteoblastic Cells by Activation of cGMP/PKG/SHP2 Pathway.
复制标题
DOI:
10.3389/fendo.2021.636784
复制
发表时间:
2021
影响因子:
5.2
通讯作者:
Wang F
中科院分区:
文献类型:
--
作者:
Wisanwattana W;Wongkrajang K;Cao DY;Shi XK;Zhang ZH;Zhou ZY;Li F;Mei QG;Wang C;Suksamrarn A;Zhang GL;Wang F
Mechanical stimulation induces bone growth and remodeling by the secondary messenger, cyclic guanosine 3’, 5’-monophosphate (cGMP), in osteoblasts. However, the role of cGMP in the regulation of estrogen biosynthesis, whose deficiency is a major cause of osteoporosis, remains unclear. Here, we found that the prenylated flavonoids, 3-O-methoxymethyl-7-O-benzylicaritin (13), 7-O-benzylicaritin (14), and 4'-O-methyl-8-isopentylkaempferol (15), which were synthesized using icariin analogs, promoted estrogen biosynthesis in osteoblastic UMR106 cells, with calculated EC50 values of 1.53, 3.45, and 10.57 µM, respectively. 14 and 15 increased the expression level of the bone specific promoter I.4-driven aromatase, the only enzyme that catalyzes estrogen formation by using androgens as substrates, in osteoblastic cells. 14 inhibited phosphodiesterase 5 (PDE5), stimulated intracellular cGMP level and promoted osteoblast cell differentiation. Inhibition of cGMP dependent-protein kinase G (PKG) abolished the stimulatory effect of 14 on estrogen biosynthesis and osteoblast cell differentiation. Further, PKG activation by 14 stimulated the activity of SHP2 (Src homology 2 domain-containing tyrosine phosphatase 2), thereby activating Src and ERK (extracellular signal-regulated kinase) signaling and increasing ERK-dependent aromatase expression in osteoblasts. Our findings reveal a previously unknown role of cGMP in the regulation of estrogen biosynthesis in the bone. These results support the further development of 14 as a PKG-activating drug to mimic the anabolic effects of mechanical stimulation of bone in the treatment of osteoporosis.
登录
查看更多内容
影响因子:
2.7
作者:
Mei Q;Wang C;Yuan W;Zhang G
通讯作者:
Zhang G
DOI:
10.1083/jcb.200610046
发表时间:
2007-02-26
期刊:
The Journal of cell biology
影响因子:
--
作者:
Ge C;Xiao G;Jiang D;Franceschi RT
通讯作者:
Franceschi RT
影响因子:
3.2
作者:
Alp, Hamit H.;Huyut, Zubeyir;Sekeroglu, Mehmet R.
通讯作者:
Sekeroglu, Mehmet R.
影响因子:
4.8
作者:
Ming, Lei-Guo;Lv, Xiang;Chen, Ke-Ming
通讯作者:
Chen, Ke-Ming
影响因子:
5
作者:
Lu, Danfeng;Yang, Lijuan;Zhang, Guolin
通讯作者:
Zhang, Guolin